Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 01:56 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma
NCT03070964 · PharmaMar · PHASE2 · terminated · last registry update 2020-10-14 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “The main reason that motivated the study termination was the slow recruitment of the trial.” | – | Registry record, PharmaMar |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against EEF1A2 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2021-09-24Results posted on the registry: PharmaMar, Plitidepsin 1.5 mg/day + Plitidepsin 2.0 mg/day (NCT04382066)
- 2021-03-05Phase 3 first posted: PharmaMar, Plitidepsin + Dexamethasone (NCT04784559)
- 2021-01-25Also stopped (terminated): Institut Bergonié, plitidepsin (NCT01876043)
- 2020-12-02Results posted on the registry: PharmaMar, plitidepsin + Bortezomib (NCT03117361)
- 2020-12-02Also stopped (terminated): PharmaMar, plitidepsin + Bortezomib (NCT03117361)
- 2020-11-24Results posted on the registry: PharmaMar, Aplidin (plitidepsin) (NCT00780975)
- 2020-11-24Also stopped (terminated): PharmaMar, Aplidin (plitidepsin) (NCT00780975)
- 2020-10-22Results posted on the registry: PharmaMar, Plitidepsin + Dexamethasone (NCT01102426)
- 2020-10-12Results posted on the registry: PharmaMar, Plitidepsin + Bortezomib (NCT02100657)
- 2020-10-12Results posted on the registry: PharmaMar, APLIDIN (plitidepsin) (NCT01149681)
- 2019-11-12Results posted on the registry: Institut Bergonié, plitidepsin (NCT01876043)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision